3-(3-氟苯氧基)丙胺 | 116753-49-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-(3-氟苯氧基)丙胺
• 中文别名: 3-(3-氟苯氧基)-1-丙胺
• 英文名称: 3-(3-Fluorophenoxy)propylamine
• 英文别名: 3-(3-fluorophenoxy)propan-1-amine
• CAS: 116753-49-2
• 化学式: C₉H₁₂FNO
• 分子量: 169.199
• InChiKey: SGTGOMOPUIFZSE-UHFFFAOYSA-N

物化性质

• 沸点：
  245.2±20.0 °C(Predicted)
• 密度：
  1.096±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(3-氟苯氧基)丙胺 在 sodium tetrahydroborate 、 甲酸 作用下， 以 水 为溶剂， 反应 3.5h， 生成 5-{[3-(3-氟-苯氧基)-丙基]-甲基-氨基}-2-异丙基-2-(3,4,5-三甲氧基-苯基)-戊腈
  参考文献：
  名称：

  Novel phenoxyalkylamine derivatives. II. Synthesis and Ca2+-antagonistic activities of .ALPHA.-alkyl-.ALPHA.-((phenoxypropylamino)propyl)-benzeneacetonitrile derivatives.

  摘要：

  含有不同取代基的α-烷基-α-[(苯氧丙胺)丙基]苯乙腈衍生物被合成，并评估了它们的Ca2+拮抗活性。在这些化合物中，具有在A环上带有3, 4, 5-(OMe)3基团、在四级碳原子上带有iso-Pr基团，以及在B环上带有m-OMe、3, 5-(OMe)2、3, 5-Me2或3, 4, 5-(OMe)3基团的N-Me衍生物被发现具有高于pA2=9的Ca2+拮抗活性。讨论了在A环、四级碳原子和B环上的取代效应。

  DOI：

  10.1248/cpb.36.373

文献信息

• SULPHONAMIDE DERIVATIVES OF BENZYLAMINE FOR THE TREATMENT OF CNS DISEASES
  申请人：ADAMED SP. Z O.O

  公开号：US20150051257A1

  公开（公告）日：2015-02-19

  Sulphonamide derivatives of benzylamine of formula (I), wherein A represents phenyl unsubstituted or substituted; or 9- or 10-membered bicyclic group, linked to —(O) x —(CH2) y — through one of its aromatic carbon atoms, consisting of benzene ring fused with -membered heteroaromatic ring containing 1 or 2 heteroatoms independently selected from the group consisting of N and O, wherein such bicyclic group is unsubstituted or substituted or with 5- or 6-membered non-aromatic heterocyclic ring having 1 or 2 O atoms, wherein heterocyclic ring is unsubstituted or substituted with one or more C 1 -C 3 -alkyls; D represents a group selected from: phenyl unsubstituted or substituted; naphthyl unsubstituted or substituted; thiophene unsubstituted or substituted; bicyclic group consisting of imidazolering fused with 5-membered non-aromatic carbocyclic ring; bicyclic group consisting of benzene ring fused with 5-membered heteroaromatic ring, having 1 or 2 heteroatoms independently selected from the group consisting of N, O and S, unsubstituted or substituted and linked to sulphonamide moiety through one of carbon atoms of benzene ring; and bicyclic group consisting of benzene ring fused with—or 6-membered non-aromatic heterocyclic ring having 1 or 2 heteroatoms independently selected from the group consisting of N and O, unsubstituted or substituted, and linked to sulphonamide moiety through one of carbon N atoms of benzene ring; R represents H or —CH 3; x is 0 or 1; y is 2 or 3; and pharmaceutically acceptable salts and solvates thereof, with the provisos that if x is 0 and y is 2, then D is naphthyl unsubstituted or substituted with one halogen atom, and if R represents —CH 3, then A is not unsubstituted or substituted phenyl. The compounds can be used in the treatment and/or prophylaxis of central nervous system disorders.

  苯甲胺的磺胺基衍生物，其化学式（I）中，A代表未取代或取代的苯基；或与—(O)x—(CH2)y—连接的9-或10-成员双环族，通过其芳香碳原子之一，由与含1或2个异原子（N和O）中独立选择的群组成的芳香环并联的苯环构成，其中此类双环族未取代或取代，或者与含1或2个O原子的5-或6-成员非芳香杂环取代或未取代，其中杂环未取代或取代为一个或多个C1-C3-烷基；D代表选自：未取代或取代的苯基；未取代或取代的萘基；未取代或取代的噻吩基；由咪唑环并联的5-成员非芳香碳环组成的双环族；由苯环并联的含1或2个异原子（N、O和S）中独立选择的群组成的5-成员杂芳环，未取代或取代，并通过苯环的一个碳原子之一与磺胺基团连接；以及由苯环并联的含1或2个异原子（N和O）中独立选择的群组成的5-或6-成员非芳香杂环取代或未取代，并通过苯环的一个碳N原子之一与磺胺基团连接；R代表H或—CH3；x为0或1；y为2或3；以及其药学上可接受的盐和溶剂合物，但如果x为0且y为2，则D为未取代或取代的萘基，且如果R代表— ，则A不是未取代或取代的苯基。这些化合物可用于治疗和/或预防中枢神经系统疾病。
• [EN] SULPHONAMIDE DERIVATIVES OF BENZYLAMINE FOR THE TREATMENT OF CNS DISEASES<br/>[FR] DÉRIVÉS DE SULFONAMIDE DE LA BENZYLAMINE POUR LE TRAITEMENT DE MALADIES DU SYSTÈME NERVEUX CENTRAL (SNC)
  申请人：ADAMED SP ZOO

  公开号：WO2013140347A1

  公开（公告）日：2013-09-26

  Sulphonamide derivatives of benzylamine of formula (I), wherein A represents phenyl unsubstituted or substituted;or 9-or 10-membered bicyclic group, linked to –(O) x - (CH 2 ) y -through one of its aromatic carbon atoms,consisting of benzene ring fused with -membered heteroaromatic ring containing 1 or 2 heteroatoms independently selected from the group consisting of N and O, wherein such bicyclic group is unsubstituted or substituted or with 5-or 6-membered non-aromaticheterocyclic ring having 1 or 2 O atoms, wherein heterocyclic ring is unsubstituted or substituted with one or more C1 -C3 - alkyls; D represents a group selected from:phenyl unsubstituted or substituted; naphthyl unsubstituted or substituted;thiophene unsubstituted or substituted;bicyclic group consisting of imidazolering fused with5-membered non-aromatic carbocyclic ring; bicyclic group consisting of benzene ring fused with 5-membered heteroaromatic ring, having 1 or 2heteroatoms independently selected from the group consisting of N, O and S, unsubstituted or substituted and linked to sulphonamide moiety through one of carbon atoms of benzene ring;and bicyclic group consisting of benzene ring fused with -or 6-membered non-aromatic heterocyclic ring having 1 or 2heteroatoms independently selected from the group consisting of N and O, unsubstituted or substituted, and linked to sulphonamide moiety through one of carbon atoms of benzene ring;R represents H or –CH 3;x is 0 or 1;yis 2 or 3;and pharmaceutically acceptable salts and solvates thereof, with the provisos that if x is 0 and y is 2, then D is naphthyl unsubstituted or substituted with one halogen atom, and if R represents –CH 3, then A is not unsubstituted or substituted phenyl. The compounds can be used in the treatment and/or prophylaxis of central nervous system disorders.

  苯甲胺的磺胺基衍生物的化学式（I），其中A代表未取代或取代的苯基；或9-或10-成员的双环族，通过其中一个芳香碳原子连接到-(O) x - (CH 2 ) y -，由苯环与含有1个或2个杂原子（从N和O组成的组中独立选择）的-成员杂芳环融合而成，其中该双环族未取代或取代，或与含有1个或2个O原子的5-或6-成员非芳杂环取代，其中杂环未取代或取代为一个或多个C1 -C3 -烷基；D代表从中选择的一组：未取代或取代的苯基；未取代或取代的萘基；未取代或取代的噻吩基；由咪唑环融合而成的5-成员非芳碳环的双环族；由苯环融合而成的含有1个或2个杂原子（从N、O和S组成的组中独立选择）的5-成员杂芳环的双环族，未取代或取代，并通过苯环的一个碳原子与磺胺基团连接；以及由苯环融合而成的5-或6-成员非芳杂环的双环族，其中杂原子独立选择自N和O组成的组，未取代或取代，并通过苯环的一个碳原子与磺胺基团连接；R代表H或-CH 3；x为0或1；y为2或3；以及其药学上可接受的盐和溶剂化合物，但是如果x为0且y为2，则D为未取代或取代的萘基且带有一个卤原子，如果R代表-CH 3，则A不是未取代或取代的苯基。这些化合物可用于治疗和/或预防中枢神经系统疾病。
• MITANI, KAZUYA;YOSHIDA, TOSHIHIKO;SAKURAI, SHUNICHIRO;MORIKAWA, KOJI;IWAN+, CHEM. AND PHARM. BULL., 36,(1988) N 1, 373-385
  作者：MITANI, KAZUYA、YOSHIDA, TOSHIHIKO、SAKURAI, SHUNICHIRO、MORIKAWA, KOJI、IWAN+

  DOI：——

  日期：——